Project Grant R01DK141277
- Federal Grant Award Summary Rutgers, The State University of New Jersey received a $235,500 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 15, 2025 through September 14, 2027, supports research investigating gut microbial functions that influence Crohn's disease (CD) risk across multiplex and non-multiplex family contexts....
- Federal Grant Award Summary Rutgers, The State University received a $175,928 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 6, 2026, with completion targeted for August 5, 2027. The research project, "Mechanism of Eph-Ephrin Signaling in Intestinal Regeneration," delivers basic biomedical research aimed at improving...
- Federal Grant Award Summary Rutgers The State University Of New Jersey, through its Robert Wood Johnson School of Health Sciences-School of Nursing, received a $802,015 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award was obligated on February 18, 2026, with a completion date of January 31, 2031. The research will be conducted at the...
- Federal Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $716,069 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning March 1, 2026 and concluding February 28, 2031. The award funds research examining the association between gestational antidepressant exposure and pediatric gastrointestinal...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $2.16 million Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) awarded August 10, 2025, with a completion date of July 31, 2029. This award funds a five-year research program investigating the metabolic regulation of immune responses to bacterial infections. The principal deliverable is...
- Federal Project Grant Award Summary St. John's University, New York received a $179,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025 through July 31, 2029. The award funds research to elucidate the physiological role of 16-alpha-hydroxylated bile acid in regulating energy intake and hepatic lipid metabolism. The...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1.62 million Project Grant through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The Research Foundation for the State University of New York, effective September 9, 2025, with a completion date of June 30, 2030. The research initiative, titled "Impact of Polymicrobial Interactions and Within-Host Adaptation on CAUTI...
- Federal Project Grant Award Summary Harvard Medical School received an $830,414 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 13, 2025, with a completion date of June 30, 2030. The award supports research focused on identifying and characterizing microbiome-derived sulfated metabolites and their biological effects on human...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $725,520 Project Grant effective September 15, 2025, through June 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates aberrant N-glycosylation in Crohn's disease as an innovative therapeutic target, focusing on patients carrying a pathogenic mutation in the...
- Federal Project Grant Award Summary Pennsylvania State University's Penn State Milton S. Hershey Medical Center received a $708,697 project grant award, effective March 1, 2026 through December 31, 2029, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research initiative investigates the inflammatory activation mechanisms of mesenchymal cells in ulcerative colitis...
Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $816,524 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective March 1, 2026 through January 31, 2031. The research project investigates the relationship between intestinal Clostridium bacteria capable of 7-dehydroxylation of bile acids and the underlying mechanisms of clinical gallstone disease. The project employs integrated multi-omics and pharmacoepidemiology methodologies, including metagenomics, metatranscriptomics, targeted metabolomics, and genetic sequencing analysis of patient fecal, serum, oral, and urine samples to characterize bacterial communities and their gene expression patterns. The research deliverables include comparative analysis of 7-dehydroxylation bacterial function across patient populations with inflammatory bowel diseases, asymptomatic gallstones, and symptomatic gallstones requiring surgical intervention, utilizing publicly available datasets and mass spectrometry techniques. This investigation aims to elucidate mechanistic understanding of how specific bacterial taxa and their metabolic functions contribute to gallstone disease pathogenesis—a condition accounting for more abdominal surgical procedures than any other digestive disease—and to identify potential therapeutic targets for this painful metabolic condition.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $816.5k | 2/26/26 |